252 related articles for article (PubMed ID: 34349837)
1. Prediction of the progression from mild cognitive impairment to Alzheimer's disease using a radiomics-integrated model.
Shu ZY; Mao DW; Xu YY; Shao Y; Pang PP; Gong XY
Ther Adv Neurol Disord; 2021; 14():17562864211029551. PubMed ID: 34349837
[TBL] [Abstract][Full Text] [Related]
2.
Peng J; Wang W; Song Q; Hou J; Jin H; Qin X; Yuan Z; Wei Y; Shu Z
Acad Radiol; 2023 Sep; 30(9):1874-1884. PubMed ID: 36587998
[TBL] [Abstract][Full Text] [Related]
3. Radiomics-Based Artificial Intelligence Differentiation of Neurodegenerative Diseases with Reference to the Volumetry.
Cheung EYW; Chau ACM; Tang FH; On Behalf Of The Alzheimer's Disease Neuroimaging Initiative
Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35455005
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Mild Cognitive Impairment Progression to Alzheimer's Disease Based on Diffusion Tensor Imaging-Derived Diffusion Parameters: Construction and Validation of a Nomogram.
Cheng X; Li D; Peng J; Shu Z; Xing X
Eur Neurol; 2023; 86(6):408-417. PubMed ID: 37926082
[TBL] [Abstract][Full Text] [Related]
5. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
6. Individualized Prediction of Early Alzheimer's Disease Based on Magnetic Resonance Imaging Radiomics, Clinical, and Laboratory Examinations: A 60-Month Follow-Up Study.
Tang L; Wu X; Liu H; Wu F; Song R; Zhang W; Guo D; Feng J; Li C
J Magn Reson Imaging; 2021 Nov; 54(5):1647-1657. PubMed ID: 33987915
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Cognitive Progression in Individuals with Mild Cognitive Impairment Using Radiomics as an Improvement of the ATN System: A Five-Year Follow-Up Study.
Song R; Wu X; Liu H; Guo D; Tang L; Zhang W; Feng J; Li C
Korean J Radiol; 2022 Jan; 23(1):89-100. PubMed ID: 34983097
[TBL] [Abstract][Full Text] [Related]
8. Predicting Alzheimer's progression in MCI: a DTI-based white matter network model.
Song Q; Peng J; Shu Z; Xu Y; Shao Y; Yu W; Yu L
BMC Med Imaging; 2024 May; 24(1):103. PubMed ID: 38702626
[TBL] [Abstract][Full Text] [Related]
9. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
10. Predicting mild cognitive impairment progression to Alzheimer's disease based on machine learning analysis of cortical morphological features.
Wang W; Peng J; Hou J; Yuan Z; Xie W; Mao G; Pan Y; Shao Y; Shu Z
Aging Clin Exp Res; 2023 Aug; 35(8):1721-1730. PubMed ID: 37405620
[TBL] [Abstract][Full Text] [Related]
11. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
12. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.
Dickerson BC; Wolk DA;
Front Aging Neurosci; 2013; 5():55. PubMed ID: 24130528
[TBL] [Abstract][Full Text] [Related]
13. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
14. T1-Weighted Imaging-Based Hippocampal Radiomics in the Diagnosis of Alzheimer's Disease.
Yin TT; Cao MH; Yu JC; Shi TY; Mao XH; Wei XY; Jia ZZ
Acad Radiol; 2024 Jun; ():. PubMed ID: 38902110
[TBL] [Abstract][Full Text] [Related]
15. Investigating predictors of progression from mild cognitive impairment to Alzheimer's disease based on different time intervals.
Wu Y; Wang X; Gu C; Zhu J; Fang Y
Age Ageing; 2023 Sep; 52(9):. PubMed ID: 37740920
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
17. Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on
Zhou P; Zeng R; Yu L; Feng Y; Chen C; Li F; Liu Y; Huang Y; Huang Z;
Front Aging Neurosci; 2021; 13():764872. PubMed ID: 34764864
[No Abstract] [Full Text] [Related]
18. Diagnostic performance of MRI radiomics for classification of Alzheimer's disease, mild cognitive impairment, and normal subjects: a systematic review and meta-analysis.
Shahidi R; Baradaran M; Asgarzadeh A; Bagherieh S; Tajabadi Z; Farhadi A; Korani SS; Khalafi M; Shobeiri P; Sadeghsalehi H; Shafieioun A; Yazdanifar MA; Singhal A; Sotoudeh H
Aging Clin Exp Res; 2023 Nov; 35(11):2333-2348. PubMed ID: 37801265
[TBL] [Abstract][Full Text] [Related]
19. Based on Tau PET Radiomics Analysis for the Classification of Alzheimer's Disease and Mild Cognitive Impairment.
Jiao F; Wang M; Sun X; Ju Z; Lu J; Wang L; Jiang J; Zuo C
Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831910
[TBL] [Abstract][Full Text] [Related]
20. Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer's Disease.
Zhou H; Jiang J; Lu J; Wang M; Zhang H; Zuo C;
Front Neurosci; 2018; 12():1045. PubMed ID: 30686995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
